Future Challenges | Diabetes on the Net

In association with the

Back to Abracadabra

Where

Online

When

September 17, 2020

TIMES

1PM & 7PM

Share on facebook
Share on twitter
Share on linkedin
Share on email
Register Now

Future Challenges


  • 1 hour 40 minute webcast

  • Live Q&A sessions with expert speakers

  • CPD accredited for 1 hour

This session features special presentations from two of the Abracadabra chairs. The first of these examines the changes in diabetes nursing over the last 20 years and the challenges for the future. This is followed by a presentation on one of the most significant recent challenges faced by diabetes nurses – the COVID-19 pandemic, and whether the upscaling of virtual clinics could have lasting impacts on everyday nursing practice. These presentations will be followed by a live Q&A session. You will then have the opportunity to join one of two breakout sessions, looking at either the progress of the Getting It Right First Time diabetes report or the assessment and management of major comorbidities associated with type 2 diabetes. Each breakout session will be followed by a further live Q&A.

Speakers

Jane Diggle

Practice Nurse with Specialist Interest in Diabetes, West Yorkshire

Nicola Milne

Community Diabetes Specialist Nurse, Manchester

Su Down

Diabetes Nurse Consultant, Somerset

Professor Partha Kar

Consultant Diabetologist, Portsmouth

Dr Kevin Fernando

GP, North Berwick, near Edinburgh

Introduction and welcome
Jane Diggle & Nicola Milne

  • Welcome, introduction to the meeting series, instructions for delegates

  • Introduction to the theme of webinar 3 and agenda

2020: The Year of the Nurse
Jane Diggle

  • WHO and the International Year of the Nurse

  • How has the role for nurses in diabetes changed over time?

  • What are the key challenges facing our profession?

Virtual clinics: Is necessity the mother of invention?
Su Down

  • How has COVID-19 changed the concept of a clinic?

  • What are the challenges

  • Platforms worth exploring

  • Personal experience of running virtual clinics

  • Adopting virtual working as part of our ‘normal’ practice

Live Q&A session
Jane Diggle, Su Down & Nicola Milne
Breakout 1: Variation of care in diabetes – and Getting It Right First Time
Professor Partha Kar

  • Status update of report

  • What we know so far about variations in hospital-based diabetes care

  • Next steps and implementation of the report findings

  • Live Q&A session

Breakout 2: Diabetes and multimorbidities
Dr Kevin Fernando

  • Overview of major comorbidities in type 2 diabetes

  • Assessing risk: calculators and other tools

  • Older and frail individuals: what does long term clinical trial evidence tell us about management?

  • Live Q&A session

Register Now
Register Now

Please click here for prescribing information for Trulicity® (dulaglutide), Humalog® (insulin lispro) (UK and ROI), Abasaglar® (insulin glargine) and Lyumjev® (insulin lispro) (Lyumjev is not available in the ROI).

For more information about Lilly products please visit www.lillydiabetes.co.uk (UK only; this link is not available in the ROI)

Adverse events and product complaints should be reported. Reporting forms and further information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store (UK) or www.hpra.ie (ROI). Adverse events and product complaints should also be reported to Lilly: please call Lilly on +44 (0) 1256 315000 (UK) or +353 (0)1 664 0446 (ROI).
These promotional virtual conferences have been developed, organised and funded by Lilly in conjunction with the
Abracadabra Programme Planning Committee.
Lilly is a registered trademark of Eli Lilly and Company © 2020 Eli Lilly and Company. All rights reserved

PP-LD-GB-0793 July 2020

© Copyright OmniaMed Communications Ltd. All rights reserved

Privacy policy / Terms and conditions

Complete the

Registration form

Your data is being collected by OmniaMed Communications on behalf of Eli Lilly and Company Ltd solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Eli Lilly and Company Ltd

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

Confirm